eCysticFibrosis Review
Jointly provided by the Johns Hopkins School of Medicine and the Institute for Johns Hopkins Nursing
Special Edition: Supported by an educational grant from Vertex Pharmaceuticals Incorporated
Jointly provided by the Johns Hopkins School of Medicine and the Institute for Johns Hopkins Nursing
Special Edition: Supported by an educational grant from Vertex Pharmaceuticals Incorporated
ADHERENCE. In this Special Edition Issue, our guest authors from the Geisel School of Medicine at Dartmouth — Dr. Alex Gifford, Associate Professor and Director of the Adult Cystic Fibrosis Program at the New Hampshire Cystic Fibrosis Center, and Senior Research Director Kathryn Sabadosa, MPH — summarize the importance of medication adherence and ways that increased clinician-patient communication can support treatment regimens that optimize adherence improvement.
TECHNOLOGY. From platforms and devices used to motivate patients to increase self-management and actively implement their care goals; to ways to reduce the isolation and stigmatization caused by the symptoms and treatment burden of the disease — technology continues to provide new ways to improve adherence and the QoL of patients with CF. The second part of this Special Edition Issue provides capsule summaries of some of the innovations showcased at the 2018 AOTC Adherence Lab at NACFC.
Senior Research Director
The Dartmouth Institute for Health Policy & Clinical Practice
Geisel School of Medicine at Dartmouth
Lebanon, NH
Associate Professor of Medicine
The Dartmouth Institute for Health Policy & Clinical Practice
Geisel School of Medicine at Dartmouth
Director, Adult Cystic Fibrosis Program, New Hampshire Cystic Fibrosis Center
Lebanon, NH
Professor of Pediatrics
Director, Cystic Fibrosis Center
Johns Hopkins University School of Medicine
Baltimore, MD
Senior Clinical Nurse
The Johns Hopkins University
Baltimore, MD
1.0 hour Physicians
1.0 contact hour Nurses
Launch date: March 15, 2019
Expiration date: March 14, 2021
